633.98 USD
▼-12.89-1.99%
盘后 634.46 0.00%
2026-11-19
市值
$17.38B
市盈率
34.46
EPS
18.03
股息率
—
52 周区间
373.00 – 693.97
成交量
167.78K
Beta
1.11
目标价
651.31
52W 低 373.0052W 高 693.97
价格走势
公司简介
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data man...